Letter to Editor on 'A randomized, controlled, blinded, parallel-group, clinical trial to study the role of Ayurcov (AyurCoro3), a one-day regimen as an adjuvant therapy for COVID-19 disease management, at dedicated Covid Hospital (DCH) in India'
Main Authors: | Bharat Krushna Khuntia, Aman Agarwal, Gautam Sharma |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-09-01
|
Series: | Complementary Therapies in Medicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0965229922000401 |
Similar Items
-
The Post-COVID 19 long term surveillance study sequel to an add-on Ayurveda regimen
by: Pankaj Wanjarkhedkar, et al.
Published: (2022-07-01) -
Ayurvedic Management of Subclinical Hypothyroidism
by: Shankar Gautam, et al.
Published: (2021-04-01) -
Report: Council for Ayurveda Research - Industry Roundtable and Global Consortium for Collaborative Research in Ayurveda, 2021
by: Pratibha Shah, et al.
Published: (2022-07-01) -
Demographic profile of COVID-19 patients reporting to the triage area of a dedicated COVID-19 hospital (DCH) in Datia, Madhya Pradesh, India
by: P. Adhikari, et al.
Published: (2024-02-01) -
Role of ayurvedic intervention in the management of anemia
by: Ishita Agarwal, et al.
Published: (2020-01-01)